跳至主要内容
临床试验/CTRI/2017/06/008746
CTRI/2017/06/008746已完成2/3 期

Role of Nimbadi eye drops in Netrabhishyanda in the special reference to infective conjunctivitis.

RUBY1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2010年9月13日最近更新:

试验速览

阶段
2/3 期
状态
已完成
发起方
RUBY
入组人数
30
试验地点
1
主要终点
Change in scores of symptoms and signs of infective conjunctivitis

研究概览

简要总结

This study has been planned to evaluate the efficacy of Nimbadi eye drops on symptoms and signsof Infective Conjunctivitis (Netrabhishyanda) as compared to Levofloxacin 0.5%ophthalmic solution on 30 patients of infective conjunctivitis. It has been planned to assess the disease condition on clinical basis.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant Blinded

入排标准

年龄范围
12.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • patients with at least 12 years of age and having clinical diagnosis of infective conjunctivitis at least in one eye.

排除标准

  • Patients with any concomitant disease of eye which could interfere with assessment of infective conjunctivitis (Netrabhishyanda) such as anterior uveitis, scleritis, episcleritis etc.
  • were excluded from the study Patients who develop any complication during the trial will be excluded.

结局指标

主要结局

Change in scores of symptoms and signs of infective conjunctivitis

时间窗: Day 2, Day 5, Day 10

次要结局

  • Change in scores of symptoms and signs of infective conjunctivitis(Day 2, Day 5, Day 10)

研究者

发起方
RUBY
申办方类型
Other [university]

研究点 (1)

Loading locations...

相似试验